Anzeige
Mehr »
Login
Montag, 04.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 869858 | ISIN: FR0000125338 | Ticker-Symbol: CGM
Tradegate
04.11.24
21:00 Uhr
161,80 Euro
-1,75
-1,07 %
1-Jahres-Chart
CAPGEMINI SE Chart 1 Jahr
5-Tage-Chart
CAPGEMINI SE 5-Tage-Chart
RealtimeGeldBriefZeit
161,55161,8523:00
161,60161,8522:00
GlobeNewswire (Europe)
221 Leser
Artikel bewerten:
(1)

Capgemini SE: Capgemini to enrich its engineering capabilities in Australia with acquisition of D+I

Media relations:
Sam Connatty
Tel.: +44 (0)370 904 3601
sam.connatty@capgemini.com

Investor relations:
Vincent Biraud
Tel.: +33 1 47 54 50 87
vincent.biraud@capgemini.com

Capgemini to enrich its engineering capabilities in Australia with acquisition of D+I

Acquisition will augment Capgemini's core engineering capabilities with product engineering and design services as part of its intelligent industry offerings

Paris, June 24, 2024 - Capgemini announced today that it has signed an agreement to acquire D+I, a leading product design and development consultancy in Australia. This acquisition will enrich the Group's intelligent industry offerings in the country, notably in the development and delivery of products from initial concepts through to production.

Founded in 1987, with R&D labs in Sydney, Melbourne and Newcastle, D+I is an award-winning team with deep expertise in mechanical engineering, and electronics product development. Specialists in services across the product life cycle, including high-precision solutions with stringent compliance accreditation and certification requirements, D+I helps its clients turn ideas into commercially successful products.

With a focus on highly appealing, human-centered solutions supported by engineering excellence, D+I has also been at the forefront of developing intricate medical, scientific and wellness devices for the last 36 years.

"As part of our intelligent industry work for clients, Capgemini is designing, developing and delivering tomorrow's connected products and services," comments William Rozé, CEO of Capgemini Engineering and Group Executive Board Member. "To do this we help organizations on the convergence between the physical and the digital worlds by developing and testing products virtually and managing them over the entire product life cycle. D+I will reinforce our product design capabilities in Australia spanning the medtech, industrial and consumer sectors. This acquisition is another example of Capgemini's growth ambition and investment in this market."

"For over 35 years D+I has been the partner of choice to leading organizations who want to create world class, commercially successful products, from research and discovery through to concept design, prototyping and into production. Capgemini's end to end intelligent industry capabilities will be a natural home for D+I's expertise. Its global reach and client base will provide unrivalled opportunities and experiences for our team members. We are excited to join the Group," said David Jones, CEO of D+I.

As a strategic business partner to its clients, Capgemini is pioneering intelligent industry - the new era of digital transformation: characterized by a growing convergence of the physical and virtual worlds in terms of products, software, data, and services. A global leader in this field, the Group is helping organizations to digitize and redefine their businesses from end to end, enabling them to transform their value chains, from intelligent products and services to intelligent supply chains and manufacturing.

The transaction is due to close in the coming months subject to regulatory approval and other customary conditions for a transaction of this nature.

About Capgemini
Capgemini is a global business and technology transformation partner, helping organizations to accelerate their dual transition to a digital and sustainable world, while creating tangible impact for enterprises and society. It is a responsible and diverse group of 340,000 team members in more than 50 countries. With its strong over 55-year heritage, Capgemini is trusted by its clients to unlock the value of technology to address the entire breadth of their business needs. It delivers end-to-end services and solutions leveraging strengths from strategy and design to engineering, all fueled by its market leading capabilities in AI, cloud and data, combined with its deep industry expertise and partner ecosystem. The Group reported 2023 global revenues of €22.5 billion.
Get The Future You Want | www.capgemini.com


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.